Affinity-based protein profiling of the antiviral natural product nanchangmycin
Nanchangmycin is a natural product with broad-spectrum activity against various organisms, exhibiting antibiotic, antiviral, anticancer, and antifibrotic effects. Nanchangmycin belongs to the family of polyether ionophores and is proposed to exert its therapeutic effects by altering ion gradients across biological membranes. Although this therapeutic mechanism has been well characterised in cancer models, it does not fully explain how nanchangmycin inhibits Zika virus infection, as recently reported. The specific molecular targets responsible for mediating nanchangmycin's antiviral activity remain unknown. Here, we designed a photoreactive clickable nanchangmycin probe and employed chemical proteomics to identify protein targets of nanchangmycin related to Zika virus infection in human cells. Among the most prominent targets was the protein SEC11A, a key component of the signal peptidase complex, which is essential for cleaving and processing Zika virus proteins. We showed that nanchangmycin blocks the cleavage of a Zika virus polyprotein, suggesting a novel mechanism for nanchangmycin-mediated inhibition of Zika virus infection.
Authors
- Daniele Mantione (ORCID: https://orcid.org/0000-0001-5495-9856)
- Emmanuelle Thinon (ORCID: https://orcid.org/0000-0001-9248-5655)
- Stéphane Claverol (ORCID: https://orcid.org/0000-0001-5315-2823)
- Santiago Leiva (ORCID: https://orcid.org/0009-0002-5825-7290)
- Chloé Freyermuth--Reymond (ORCID: https://orcid.org/0009-0002-7588-4114)
Institutions
- Ikerbasque (ES)
- Centre National de la Recherche Scientifique (FR)
- Université de Bordeaux (FR)
- University of the Basque Country (ES)
- Polymat (ES)
- Bordeaux Population Health (FR)
- Chimie et Biologie des Membranes et des Nanoobjects (FR)
- Institut Européen de Chimie et Biologie (FR)
- Institut Polytechnique de Bordeaux (FR)
Publication Details
- Journal
- RSC Chemical Biology
- Published
- 2025-10-21
- DOI
- https://doi.org/10.1039/d5cb00126a
- Primary Topic
- Monoclonal and Polyclonal Antibodies Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Agence Nationale de la Recherche
- Institut National de la Santé et de la Recherche Médicale
- Centre National de la Recherche Scientifique
- Université de Bordeaux